TrialJournal of hematology & oncology2011

Two-dose-level confirmatory study of the pharmacokinetics and tolerability of everolimus in Chinese patients with advanced solid tumors.

BingHe Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.